You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

serine

Showing 26 - 50 of 579
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg, Drug: Standard

Not yet recruiting
  • Covid19
  • Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg
  • Drug: Standard treatment Standard treatment
  • (no location specified)
Oct 23, 2020

COVID19 Trial in Padova (Nafamostat Mesilate, Placebo)

Recruiting
  • COVID19
  • Nafamostat Mesilate
  • Placebo
  • Padova, Italy
    Azienda Ospedale Università di Padova
Jun 4, 2021

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

Active, not recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Aldesleukin
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 3, 2022

Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • Aldesleukin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 15, 2021

Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

Active, not recruiting
  • Metastatic Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +11 more
  • Aldesleukin
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 13, 2022

HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston

Active, not recruiting
  • HLA-A*0201 Positive Cells Present
  • +3 more
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck, Stage IIIA Skin Melanoma Trial in New Brunswick

Active, not recruiting
  • Metastatic Melanoma
  • +8 more
  • Aldesleukin
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

Intracerebral Hemorrhage Trial in Singapore (Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2)., 0.9%

Recruiting
  • Intracerebral Hemorrhage
  • Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2).
  • 0.9% Sodium-chloride
  • Singapore, Singapore
    National Neuroscience Institute
Mar 2, 2021

Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester

Not yet recruiting
  • Clinical Stage IV Gastric Cancer AJCC v8
  • +4 more
  • Aldesleukin
  • +10 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 5, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

Recruiting
  • Bone Sarcoma
  • +15 more
  • Aldesleukin
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

Terminated
Has Results
  • Advanced Pleural Malignant Mesothelioma
  • +10 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2021

Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)

Recruiting
  • Liposarcoma
  • Atypical Lipomatous Tumor
  • Blood sampling
  • Montpellier, France
    Institut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022

Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))

Completed
  • Hepatitis C Virus Infection
  • OBV/PTV/r) ± ribavirin (RBV)
  • (no location specified)
May 9, 2020

Liver Cancer Trial in Chang chun (FAPI PET)

Recruiting
  • Liver Cancer
  • FAPI PET
  • Chang chun, Jilin, China
    China-Japan Union Hospital
Mar 28, 2023

Alzheimer, Parkinson Disease Trial in Antalya, Istanbul (Metabolic Cofactor Supplementation, Sorbitol)

Completed
  • Alzheimer Disease
  • Parkinson Disease
  • Metabolic Cofactor Supplementation
  • Sorbitol
  • Antalya, Turkey
  • +1 more
Aug 5, 2022

Chronic Hepatitis C Virus Infection Trial in Beni-Suef (SOF plus (OBV/PTV/r) plus RBV)

Completed
  • Chronic Hepatitis C Virus Infection
  • SOF plus (OBV/PTV/r) plus RBV
  • Beni-Suef, Egypt
    Beni-Suef University
May 13, 2020